A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin (Q42931947)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 August 2010
edit
Language Label Description Also known as
English
A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin
scientific article published on 19 August 2010

    Statements

    A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin (English)
    Gerald W Tannock
    Karen Munro
    Corinda Taylor
    Blair Lawley
    Brendan Byrne
    Judy Emery
    Thomas Louie
    19 August 2010
    Pt 11
    3354-3359

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit